F M LaForce, T C Eickhoff. Show Affiliations »
Abstract
Mesh: See more » AgedBacterial VaccinesCost-Benefit AnalysisHumansLung Diseases/complicationsPneumococcal Infections/prevention & controlPneumococcal VaccinesSepsis/prevention & control
Substances: See more » Bacterial VaccinesPneumococcal Vaccines
Year: 1986 PMID: 3079635 DOI: 10.7326/0003-4819-104-1-110
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391